Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 7667 Download: 106 Web of Science: 3 Crossref: 4

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy

Myung Jin Oh, Heon Ju Lee, Si Hyung Lee

Clin Mol Hepatol. 2013;19(3):288-299. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.288

View: 8647 Download: 75 Crossref: 10

The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care

Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee

Clin Mol Hepatol. 2011;17(3):189-198. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.189

View: 7428 Download: 71 Crossref: 6

3

Prevalence and Risk Factors of Significant Intrapulmonary Shunt in Cirrhotic patients awaiting liver transplantation

Ji Min Lee,Moon Seok Choi,Sang Chol Lee,Seung Woo Park,Mun Hee Bae,Joon Hyeok Lee,Kwang Cheol Koh,Seung Woon Paik,Poong Lyul Rhee,Jae Jun Kim,Jong Chul Rhee

Clin Mol Hepatol. 2002;8(3):271-276. Published online January 1, 2000

View: 2428 Download: 24

1 |

Viewed By 6001	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5524	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 5308	MAFLD: How is it different from NAFLD?
Viewed By 5279	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4861	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 146	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 109	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search